Payment overview · 2025
General Payments
$57.49
3 reported records · 3 companies
Healthcare provider profile · identity verified
Tanweer A Memon, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · PORT CHARLOTTE, FL · NPI 1053304774
Verified facts
What the public records show
CMS Open Payments records show Tanweer A Memon, M.D. received $57.49 in general payments during 2025 across 3 reported records.
SI-BONE, INC. accounted for 47.1% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| SI-BONE, INC. | Unresolved — no canonical attribution shown | $27.09 | 47.1% | 1 | 2025 |
| AGEPHA Pharma FZ LLC | Unresolved — no canonical attribution shown | $16.05 | 27.9% | 1 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $14.35 | 25.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $57.49 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| LODOCO Normalized: lodoco |
Drug | AGEPHA Pharma FZ LLC | $16.05 | 1 | 2025 |
Source payment records
|
|||||
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $14.35 | 1 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $14.35 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Oxycodone Hcl | Oxycodone Hcl | 870 | 92 |
| Morphine Sulfate Er | Morphine Sulfate | 640 | 72 |
| Alprazolam | Alprazolam | 422 | 72 |
| Levothyroxine Sodium | Levothyroxine Sodium | 397 | 102 |
| Pantoprazole Sodium | Pantoprazole Sodium | 366 | 117 |
| Gabapentin | Gabapentin | 333 | 89 |
| Furosemide | Furosemide | 278 | 92 |
| Amlodipine Besylate | Amlodipine Besylate | 273 | 79 |
| Atorvastatin Calcium | Atorvastatin Calcium | 273 | 82 |
| Methylprednisolone | Methylprednisolone | 263 | 154 |
| Metoprolol Tartrate | Metoprolol Tartrate | 254 | 82 |
| Lisinopril | Lisinopril | 246 | 73 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 246 | 44 |
| Azithromycin | Azithromycin | 242 | 140 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 229 | 69 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 227 | 73 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 224 | 41 |
| Tamsulosin Hcl | Tamsulosin Hcl | 177 | 50 |
| Pregabalin | Pregabalin | 175 | 37 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 174 | 60 |
| Losartan Potassium | Losartan Potassium | 172 | 53 |
| Omeprazole | Omeprazole | 161 | 54 |
| Meloxicam | Meloxicam | 160 | 50 |
| Eliquis | Apixaban | 159 | 49 |
| Metformin Hcl | Metformin Hcl | 157 | 47 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 155 | 43 |
| Metoprolol Succinate | Metoprolol Succinate | 151 | 46 |
| Clopidogrel | Clopidogrel Bisulfate | 147 | 46 |
| Zolpidem Tartrate | Zolpidem Tartrate | 147 | 23 |
| Potassium Chloride | Potassium Chloride | 140 | 53 |
| Trazodone Hcl | Trazodone Hcl | 140 | 34 |
| Escitalopram Oxalate | Escitalopram Oxalate | 136 | 37 |
| Hydromorphone Hcl | Hydromorphone Hcl | 125 | 16 |
| Simvastatin | Simvastatin | 124 | 39 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 121 | 35 |
| Hydrochlorothiazide | Hydrochlorothiazide | 114 | 34 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 110 | 26 |
| Allopurinol | Allopurinol | 106 | 31 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 106 | 82 |
| Linzess | Linaclotide | 103 | 31 |
| Ozempic | Semaglutide | 99 | 26 |
| Sertraline Hcl | Sertraline Hcl | 95 | 26 |
| Tizanidine Hcl | Tizanidine Hcl | 93 | 21 |
| Duloxetine Hcl | Duloxetine Hcl | 91 | 22 |
| Prednisone | Prednisone | 90 | 35 |
| Temazepam | Temazepam | 87 | 18 |
| Montelukast Sodium | Montelukast Sodium | 86 | 26 |
| Clonazepam | Clonazepam | 85 | 13 |
| Sucralfate | Sucralfate | 83 | 26 |
| Pravastatin Sodium | Pravastatin Sodium | 81 | 26 |
| Anastrozole | Anastrozole | 78 | 21 |
| Vascepa | Icosapent Ethyl | 77 | 24 |
| Tramadol Hcl | Tramadol Hcl | 74 | 37 |
| Doxycycline Hyclate | Doxycycline Hyclate | 68 | 51 |
| Fluticasone Propionate | Fluticasone Propionate | 68 | 33 |
| Citalopram Hbr | Citalopram Hydrobromide | 63 | 17 |
| Glipizide | Glipizide | 63 | 20 |
| Famotidine | Famotidine | 59 | 21 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 58 | 30 |
| Donepezil Hcl | Donepezil Hcl | 58 | 11 |
| Carvedilol | Carvedilol | 57 | 21 |
| Glipizide Er | Glipizide | 55 | 14 |
| Testosterone Cypionate | Testosterone Cypionate | 53 | 15 |
| Ondansetron Odt | Ondansetron | 52 | 18 |
| Spironolactone | Spironolactone | 52 | 20 |
| Warfarin Sodium | Warfarin Sodium | 52 | suppressed |
| Finasteride | Finasteride | 51 | 17 |
| Jardiance | Empagliflozin | 50 | 15 |
| Morphine Sulfate | Morphine Sulfate | 50 | suppressed |
| Colchicine | Colchicine | 48 | 16 |
| Fluoxetine Hcl | Fluoxetine Hcl | 44 | 12 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 44 | 12 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 42 | suppressed |
| Carisoprodol | Carisoprodol | 42 | suppressed |
| Atenolol | Atenolol | 41 | 11 |
| Amoxicillin | Amoxicillin | 40 | 27 |
| Januvia | Sitagliptin Phosphate | 39 | suppressed |
| Creon | Lipase/Protease/Amylase | 38 | 13 |
| Ibuprofen | Ibuprofen | 38 | 15 |
| Olanzapine | Olanzapine | 38 | suppressed |
| Trulicity | Dulaglutide | 38 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 37 | suppressed |
| Lorazepam | Lorazepam | 36 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 35 | suppressed |
| Entresto | Sacubitril/Valsartan | 35 | 11 |
| Estradiol | Estradiol | 35 | suppressed |
| Myrbetriq | Mirabegron | 35 | suppressed |
| Acyclovir | Acyclovir | 34 | 19 |
| Cefdinir | Cefdinir | 33 | 31 |
| Xtampza Er | Oxycodone Myristate | 33 | suppressed |
| Mounjaro | Tirzepatide | 32 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 31 | suppressed |
| Fentanyl | Fentanyl | 31 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 31 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 30 | 24 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 30 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 28 | 13 |
| Hydralazine Hcl | Hydralazine Hcl | 28 | suppressed |
| Levofloxacin | Levofloxacin | 28 | 21 |
| Digoxin | Digoxin | 27 | suppressed |
| Methocarbamol | Methocarbamol | 27 | suppressed |
| Nystatin | Nystatin | 27 | 17 |
| Amiodarone Hcl | Amiodarone Hcl | 26 | 12 |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 26 | suppressed |
| Zenpep | Lipase/Protease/Amylase | 26 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 25 | suppressed |
| Aripiprazole | Aripiprazole | 25 | suppressed |
| Memantine Hcl | Memantine Hcl | 25 | suppressed |
| Vilazodone Hcl | Vilazodone Hcl | 25 | suppressed |
| Levetiracetam | Levetiracetam | 24 | suppressed |
| Naproxen | Naproxen | 24 | 13 |
| Valacyclovir | Valacyclovir Hcl | 24 | 13 |
| Dexlansoprazole Dr | Dexlansoprazole | 23 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 23 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 22 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 22 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 22 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 22 | 12 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 21 | suppressed |
| Folic Acid | Folic Acid | 21 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 21 | suppressed |
| Metronidazole | Metronidazole | 21 | 16 |
| Oxycontin | Oxycodone Hcl | 21 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 21 | suppressed |
| Baclofen | Baclofen | 20 | suppressed |
| Fluconazole | Fluconazole | 20 | 17 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 20 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 20 | suppressed |
| Ezetimibe | Ezetimibe | 19 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 19 | suppressed |
| Lidocaine | Lidocaine | 19 | suppressed |
| Nurtec Odt | Rimegepant Sulfate | 19 | suppressed |
| Repatha Sureclick | Evolocumab | 19 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 19 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 18 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 18 | suppressed |
| Glimepiride | Glimepiride | 18 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Nitroglycerin | Nitroglycerin | 17 | 12 |
| Ondansetron Hcl | Ondansetron Hcl | 17 | suppressed |
| Restasis | Cyclosporine | 17 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 16 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 16 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 15 | suppressed |
| Novolog Flexpen | Insulin Aspart | 15 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 14 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 14 | suppressed |
| Metolazone | Metolazone | 14 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 14 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 14 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Butorphanol Tartrate | Butorphanol Tartrate | 13 | suppressed |
| Cephalexin | Cephalexin | 13 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 13 | suppressed |
| Lamotrigine | Lamotrigine | 13 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 13 | suppressed |
| Oxymorphone Hcl Er | Oxymorphone Hcl | 13 | suppressed |
| Vraylar | Cariprazine Hcl | 13 | suppressed |
| Acarbose | Acarbose | 12 | suppressed |
| Bupropion Xl | Bupropion Hcl | 12 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 12 | suppressed |
| Gemtesa | Vibegron | 12 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 12 | suppressed |
| Bumetanide | Bumetanide | 11 | suppressed |
| Dexamethasone | Dexamethasone | 11 | suppressed |
| Humulin R | Insulin Regular, Human | 11 | suppressed |
| Latanoprost | Latanoprost | 11 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 11 | suppressed |
| Repatha Syringe | Evolocumab | 11 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $57.49 · 3 records | SI-BONE, INC. | LODOCO, OTEZLA, REPATHA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error